Psychemedics Corp.  

(Public, NASDAQ:PMD)   Watch this stock  
Find more results for PMD
14.74
+0.48 (3.37%)
May 29 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 14.10 - 14.74
52 week 12.42 - 17.83
Open 14.10
Vol / Avg. 10,760.00/14,173.00
Mkt cap 76.67M
P/E 29.07
Div/yield 0.15/4.07
EPS 0.51
Shares 5.38M
Beta 0.92
Inst. own 51%
Apr 27, 2015
Q1 2015 Psychemedics Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin 4.11% 10.98%
Operating margin 6.67% 16.06%
EBITD margin - 19.65%
Return on average assets 4.74% 15.78%
Return on average equity 8.80% 25.53%
Employees 156 -
CDP Score - -

Address

Suite 200, 125 Nagog Park
ACTON, MA 01720
United States - Map
+1-800-6288073 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Psychemedics Corporation is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The Company’s testing methods utilize a technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. This is fundamental to the entire process because the patented method gets virtually 100% of the drug out of the hair, and if you cannot get the drug out of the hair, you cannot measure it. The Company then performs a custom-designed enzyme immunoassay (EIA) on the liquid supernatant, with confirmation testing by mass spectrometry. The testing services are performed at the Company’s laboratory at Culver City, California.

Officers and directors

Raymond C Kubacki Jr. Chairman of the Board, President, Chief Executive Officer
Age: 70
Bio & Compensation  - Reuters
Neil L. Lerner Vice President - Finance
Age: 47
Bio & Compensation  - Reuters
Michael I. Schaffer Ph.D. Vice President - Laboratory Operations
Age: 70
Bio & Compensation  - Reuters
James V. Dyke Corporate Vice President - Sales and Marketing
Age: 50
Bio & Compensation  - Reuters
Harry F. Connick Sr. Independent Director
Age: 89
Bio & Compensation  - Reuters
Walter S. Tomenson Jr. Independent Director
Age: 68
Bio & Compensation  - Reuters
Fred J. Weinert Independent Director
Age: 67
Bio & Compensation  - Reuters